NCT03737695 - Clinical Information and Biospecimen Collection From Patients With Recurrent or Stage IV Breast Cancer | Biotech Hunter

Enrollment

300

Participants

Timeline

Start Date

September 16, 2019

Primary Completion Date

September 15, 2026

Study Completion Date

May 15, 2029

Conditions

Anatomic Stage IV Breast Cancer AJCC v8Invasive Breast CarcinomaMetastatic Breast CarcinomaPeritoneal EffusionRecurrent Breast Carcinoma

Interventions

PROCEDURE

Biospecimen Collection

Undergo biospecimen collection

OTHER

Medical Chart Review

Undergo clinical information collection

Trial Locations (14)

Montefiore Medical Center-Einstein Campus, The Bronx

UPMC-Magee Womens Hospital, Pittsburgh

University of Pennsylvania/Abramson Cancer Center, Philadelphia

MedStar Georgetown University Hospital, Washington D.C.

Johns Hopkins University/Sidney Kimmel Cancer Center, Baltimore

UNC Lineberger Comprehensive Cancer Center, Chapel Hill

Duke University Medical Center, Durham

University of Alabama at Birmingham Cancer Center, Birmingham

Vanderbilt Breast Center at One Hundred Oaks, Nashville

Mayo Clinic in Rochester, Rochester

University of Chicago Comprehensive Cancer Center, Chicago

UCSF Medical Center-Mission Bay, San Francisco

FHCC South Lake Union, Seattle

Dana-Farber Cancer Institute, Boston